CDMO Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Leading Players in the Contract Development and Manufacturing Organization (CDMO) Market

The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Vetter Pharma-Fertigung GmbH & Co. KG

Vetter Pharma-Fertigung GmbH & Co. KG is a pharmaceutical services provider specializing in aseptic manufacturing and fill-and-finish solutions across clinical development through commercial production. The company offers drug product development, aseptic filling, visual inspection, device assembly and packaging, analytical testing, regulatory support, and logistics services to biopharmaceutical clients. With more than seven decades of experience and a global workforce exceeding 7,300 employees, Vetter supports complex injectable therapies and advanced biologics, strengthening its position as a trusted partner for scalable manufacturing, quality assurance, and compliance throughout the product lifecycle.

Recipharm AB

Recipharm AB is a contract development and manufacturing organization offering end-to-end solutions across drug development and commercial production. The company provides development and manufacturing services for solid, semi-solid, and liquid dosage forms, along with sterile fill-finish capabilities for biologics and small molecules. Its advanced biologics segment supports GMP manufacturing of ATMPs, including plasmids, xRNA, viral vectors, and microbiome products. With multiple facilities across several countries, the company delivers flexible, scalable services, strengthening its role in supporting pharmaceutical and biotechnology partners throughout complex development and manufacturing lifecycles.

Boehringer Ingelheim

Boehringer Ingelheim is a pharmaceutical company with a strong presence in contract development and manufacturing through its BioXcellence™ division. The company provides comprehensive services for late-stage biopharmaceuticals, including mammalian and microbial manufacturing and aseptic filling. With more than 40 years of biotechnology expertise and a global network of facilities, it has supported the development of over 45 therapies. By collaborating with partners to produce complex biologics for challenging diseases, the company plays a significant role in advancing outsourced biopharmaceutical manufacturing and innovation.

Patheon Pharma Services (Thermo Fisher Scientific Inc.)

Thermo Fisher Scientific Inc., through its Patheon Pharma Services division, is a prominent provider of integrated contract development and manufacturing solutions for pharmaceutical and biotechnology companies. The company offers end-to-end capabilities spanning early-stage research and development, clinical trial support, and commercial manufacturing, enabling sponsors to streamline drug development timelines. Its 360-degree CDMO and CRO service portfolio supports complex biologics and small molecules, positioning the organization as a strategic partner in advancing innovative therapies and improving market access through efficient development and production processes.

Other key players in the market are Pfizer Inc., Famar SA, Lonza Group, LTS Lohmann Therapie-Systeme AG, Aenova Holding GmBH, Fareva SA, FUJIFILM Diosynth Biotechnologies, eXmoor Pharma, B. Braun SE, and Sanofi.

Contract Development and Manufacturing Organization (CDMO) Market Report Snapshots

Contract Development and Manufacturing Organization (CDMO) Market